Meth/amphetamine use and associated HIV: Implications for global policy and public health

International Journal of Drug Policy

Volumn 21, Issue 5, 2010, Pages 347-358

  Degenhardt, Louisa ^a   Mathers, Bradley ^a   Guarinieri, Mauro ^a   Panda, Samiran ^a   Phillips, Benjamin ^a   Strathdee, Steffanie A ^a   Tyndall, Mark ^a   Wiessing, Lucas ^a   Wodak, Alex ^a   Howard, John ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Amphetamine; Epidemiology; HIV; Injecting; Methamphetamine; Policy; Public health

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE; METHAMPHETAMINE;

DRUG ABUSE; DRUG DEPENDENCE; DRUG TRAFFIC; DRUG USE; GEOGRAPHIC DISTRIBUTION; HEPATITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INTRAVENOUS DRUG ABUSE; LAW; POLICY; PRIORITY JOURNAL; RISK FACTOR; SEXUAL BEHAVIOR; SEXUAL TRANSMISSION; SHORT SURVEY; SUBSTANCE ABUSE; VIRUS TRANSMISSION; WORK ENVIRONMENT;

AMPHETAMINE-RELATED DISORDERS; FEMALE; HEALTH POLICY; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; METHAMPHETAMINE; PUBLIC HEALTH; SUBSTANCE ABUSE, INTRAVENOUS; WORLD HEALTH;

EID: 77954624502     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugpo.2009.11.007     Document Type: Short Survey

References (153)

1. AbuMadini M., Rahim S., Al-Zahrani M., Al-Johi A. Two decades of treatment seeking for substance use disorders in Saudi Arabia: Trends and patterns in a rehabilitation facility in Dammam. Drug and Alcohol Dependence 2008, 97:231-236.
2. Adamson S., Sellman D., Deering D., Robertson P., de Zwart K. Alcohol and drug treatment population profile: a comparison of 1998 and 2004 data in New Zealand. New Zealand Medical Journal 2006, 119(1244):U2284. [see comment].
3. Aden A., Dimba E.A.O., Ndolo U.M., Chindia M.L. Socio-economic effects of khat chewing in north eastern Kenya. East African Medical Journal 2006, 83(3):69-73.
4. Ahmad K. Asia grapples with spreading amphetamine abuse. Lancet 2003, 361(9372):1878-1879.
5. Ahmadi J., Benrazavi L. Substance use among Iranian cardiovascular patients. European Journal of Medical Research 2002, 7(2):89-92.
6. Ahmadi J., Benrazavi L. Substance use among Iranian nephrologic patients. American Journal of Nephrology 2002, 22(1):11-13.
7. Ahmadi J., Fakoor A., Pezeshkian P., Khoshnood R., Malekpour A. Substance use among Iranian psychiatric inpatients. Psychological Reports 2001, 89(2):363-365.
8. Al-Habori M. The potential adverse effects of habitual use of Catha edulis (khat). Expert Opinion on Drug Safety 2005, 4(6):1145-1154.
9. Al-Motarreb A., Baker K., Broadley K.J. Khat: pharmacological and medical aspects and its social use in Yemen. Phytotherapy Research 2002, 16(5):403-413.
10. Allam H. A drive with a Saudi woman. Middle East Diary 2007, Retrieved from http://washingtonbureau.typepad.com/cairo/2007/05/a_drive_with_a_.html.
11. Models of intervention and care for psychostimulant users. NDS Monograph Series No. 51 2004, Australian Government Department of Health and Ageing, Canberra. 2nd ed. A. Baker, N. Lee, J. Jenner (Eds.).
12. Beyrer C., Razak M.H., Jittiwutikarn J., Suriyanon V., Vongchak T., Srirak N., et al. Methamphetamine users in northern Thailand: Changing demographics and risks for HIV and STD among treatment-seeking substance abusers. International Journal of STD & AIDS 2004, 15:697-704.
13. Bohning D., Suppawattanabodee B., Kusolvisitku W., Viwatwongkasem C. Estimating the number of drug users in Bangkok 2001: A capture-recapture approach using repeated entries in one list. European Journal of Epidemiology 2004, 19:1075-1083.
14. Bolding G., Hart G., Sherr L., Elford J. Use of crystal methamphetamine among gay men in London. Addiction 2006, 101(11):1622-1630.
15. Braine N., Des Jarlais D.C., Goldblatt C., Zadoretzky C., Turner C. HIV risk behavior among amphetamine injectors at U.S. syringe exchange programs. AIDS Education & Prevention 2005, 17(6):515-524.
16. Brouwer K.C., Case P., Ramos R., Magis-Rodriguez C., Bucardo J., Patterson T.L., et al. Trends in production, trafficking, and consumption of methamphetamine and cocaine in Mexico. Substance Use & Misuse 2006, 41(5):707-727.
17. Buavirat A., Page-Shafer K., van Griensven G.J.P., Mandel J.S., Evans J., Chuaratanaphong J., et al. Risk of prevalent HIV infection associated with incarceration among injecting drug users in Bangkok. Thailand: Case-control study. British Medical Journal 2003, 326(7384):308.
18. Bureau for International Narcotics, Law Enforcement Affairs International Narcotics Control Strategy Report: Volume I: drug and chemical control 2004, US Department of State, Washington.
19. Calabria B., Phillips B., Singleton J., Mathers B., Congreve E., Degenhardt L., et al. Searching the grey literature to access information on drug and alcohol research. NDARC Technical Report No. 293 2008, National Drug and Alcohol Research Centre, University of NSW, Sydney, http://ndarc.med.unsw.edu.au/NDARCWeb.nsf/page/Reports.
20. Callaghan R.C., Brands B., Taylor L., Lentz T., Callaghan R.C., Brands B., et al. The clinical characteristics of adolescents reporting methamphetamine as their primary drug of choice: an examination of youth admitted to inpatient substance-abuse treatment in northern British Columbia, Canada, 2001-2005. [Comparative Study Research Support Non-U. S. Gov't]. Journal of Adolescent Health 2007, 40(3):286-289.
21. Caribbean Drug Abuse Epidemiology, Surveillance System Project Bahamas Secondary School Survey 2003, Bahamsa National Drug Council, Bahamas.
22. Caribbean Epidemiology Centre The Caribbean HIV/AIDS epidemic and the situation in member countries of the Caribbean Epidemiology Centre (CAREC) 2007, Caribbean Epidemiology Centre.
23. Case P., Ramos R., Brouwer K., Firestone-Cruz M., Pollini R., Strathdee S., et al. At the borders, on the edge: Use of injected Methamphetamine in Tijuana and Ciudad Juarez, Mexico. Journal of Immigrant and Minority Health 2008, 10(1):23-33.
24. Castiglioni S., Zuccato E., Crisci E., Chiabrando C., Fanelli R., Bagnati R. Identification and measurement of illicit drugs and their metabolites in urban wastewater by liquid chromatography-tandem mass spectrometry. Analytical Chemistry 2006, 78(24):8421-8429.
25. Centre for Social and Health Outcomes Research and Evaluation Recent trends in illegal drug use in New Zealand 2006 2006, Massey University, Auckland.
26. Chamla D., Chamla J.H., Dabin W., Delin H., Rennes N. Transition to injection and sharing of needles/syringes: Potential for HIV transmission among heroin users in Chengdu, China. Addictive Behaviors 2006, 31:697-701.
27. Cheng Y., Sherman S.G., Srirat N., Vongchak T., Kawichai S., Jittiwutikarn J., et al. Risk factors associated with injection initiation among drug users in Northern Thailand. Harm Reduction Journal 2006, 3:10.
28. Chesher G. Pharmacology of the sympathomimetic psychostimulants. Illicit psychostimulant use in Australia 1993, 9-30. Australian Government Publishing Service, Canberra. D. Burrows, B. Flaherty, M. MacAvoy (Eds.).
29. Chintalova-Dallas R., Case P., Kitsenko N., Lazzarini Z. Boltushka: A homemade amphetamine-type stimulant and HIV risk in Odessa, Ukraine. International Journal of Drug Policy 2009, 20(4):347-351.
30. Cho A.K., Melega W.P. Patterns of methamphetamine abuse and their consequences. Journal of Addictive Diseases 2002, 21(1):21-34.
31. Chouvy P.A., Meissonnier J. Yaa baa: Production traffic and consumption of methamphetamine in mainland Southeast Asia 2004, Singapore University Press, Singapore.
32. Cunningham J.K., Liu L.-M. Impacts of federal ephedrine and pseudoephedrine regulations on methamphetamine-related hospital admissions [Research Report]. Addiction 2003, 98(9):1229-1237. September 2003.
33. Cunningham J.K., Liu L.-M. Impacts of federal precursor chemical regulations on methamphetamine arrests. Addiction 2005, 100(4):479-488. April 2005.
34. Dangerous Drugs Board A pilot study on nalbuphine hydroschloride abuse in Cebu and metro Manila 2005, Dangerous Drugs Board of the Phillippines, Manila.
35. Darke S., Cohen J., Ross J., Hando J., Hall W. Transitions between routes of administration of regular amphetamine users. Addiction 1994, 89(9):1077-1083.
36. Darke S., Hall W. Levels and correlates of polydrug use among heroin users and regular amphetamine users. Drug & Alcohol Dependence 1995, 39:231-235.
37. de Kort G., Batra S., Pasaribu R., Vazirian M., Ul-Hassan S. Young people and drugs: Towards a comprehensive health promotion policy 2005, Asian Harm Reduction Network, Chiang Mai.
38. Degenhardt L., Mathers B., Guarinieri M., Panda S., Phillips B., Strathdee S., et al. The global epidemiology of methamphetamine injection: A review of the evidence on use and associations with HIV and other harm 2007, National Drug and Alcohol Research Centre, University of NSW, Sydney, Accessible at: http://notes.med.unsw.edu.au/IDURGWeb.nsf/resources/thematic+papers/$file/methamphetamine+injecting+and+HIV+review.pdf.
39. Degenhardt L., Roxburgh A., Black E., Kinner S., Campbell G., Bruno R., et al. The epidemiology of methamphetamine use and harm in Australia. Drug and Alcohol Review 2008, 27(3):243-252.
40. Diaz R.M., Heckert A.L., Sanchez J. Reasons for stimulant use among Latino gay men in San Francisco: a comparison between methamphetamine and cocaine users. Journal of Urban Health 2005, 82(1 Suppl. 1).
41. Dormitzer C.M., Gonzalez G.B., Penna M., Bejarano J., Obando P., Sanchez M., et al. The PACARDO research project: youthful drug involvement in Central America and the Dominican Republic. Pan American Journal of Public Health 2004, 15(6):400-416.
42. Drumright L., Patterson T., Strathdee S. Club drugs as causal risk factors for HIV acquisition among men who have sex with men: A review. Substance Use & Misuse 2006, 41:1551-1601.
43. EMCDDA 2005 REITOX National Report on the drug situation in Denmark 2005, EMCDDA, Lisbon.
44. EMCDDA 2005 REITOX National Report on the drug situation in Finland 2005, EMCDDA, Lisbon.
45. EMCDDA 2005 REITOX National Report on the drug situation in France 2005, EMCDDA, Lisbon.
46. EMCDDA 2005 REITOX National Report on the drug situation in Germany 2005, EMCDDA, Lisbon.
47. EMCDDA 2005 REITOX National Report on the drug situation in Hungary 2005, EMCDDA, Lisbon.
48. EMCDDA 2005 REITOX National Report on the drug situation in Netherlands 2005, EMCDDA, Lisbon.
49. EMCDDA 2005 REITOX National Report on the drug situation in Poland 2005, EMCDDA, Warsaw.
50. EMCDDA 2005 REITOX National Report on the drug situation in Slovakia 2005, EMCDDA, Lisbon.
51. EMCDDA 2005 REITOX National Report on the drug situation in the Czech Republic 2005, EMCDDA, Lisbon.
52. EMCDDA 2005 REITOX National Report on the drug situation in the United Kingdom 2005, UK Department of Health, London.
53. Emonson D., Vanderbeek R. The use of ampehtamines in US air force tactical operations during Desert Shield and Storm. Aviation, Space and Environmental Medicine 1995, 66:260-263.
54. HIV/AIDS treatment and care for injecting drug users: Clinical protocol for the WHO European Region 2006, World Health Organization Regional Office for Europe, Copenhagen. I. Eramova, S. Matic, M. Munz (Eds.).
55. Fairbairn N., Kerr T., Buxton J.A., Li K., Montaner J.S., Wood E. Increasing use and associated harms of crystal methamphetamine injection in a Canadian setting [Short Communication]. Drug and Alcohol Dependence 2007, 88(2-3):313-316.
56. Farrell M., Marsden J., Ali R., Ling W. Methamphetamine: drug use and psychoses becomes a major public health issue in the Asia Pacific region. Addiction 2002, 97(7):771-772.
57. Gossop M., Griffiths P., Powis B., Strang J. Severity of dependence and route of administration of heroin, cocaine and amphetamines. British Journal of Addiction 1992, 87:1527-1536.
58. Grabowski J., Shearer J., Merrill J., Negus S.S. Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence. Addictive Behaviors 2004, 29(7):1439-1464.
59. Grant K., Sinclair Kelley S., Agrawal S., Meza J.L., Meyer J.R., Romberger D.J. Methamphetamine use in rural midwesterners. American Journal on Addictions 2007, 16(2):79-84.
60. Grund, J.-P., Zabransky, T., Irwin, K., & Heimer, R. (2009). Chapter 13. Stimulant use in Central and Eastern EUrope: How recent social history shaped current drug consumption patterns (pp. 173-202).
61. Hacker M.A., Malta M., Enriquez M., Bastos F.I. Human immunodeficiency virus, AIDS, and drug consumption in South America and the Caribbean: Epidemiological evidence and initiatives to curb the epidemic. Pan American Journal of Public Health 2005, 18(4-5):303-313.
62. Halkitis P., Parsons J.T., Stirratt M. A double epidemic: Crystal methamphetamine use in relation to HIV transmission among gay men. Journal of Homosexuality 2001, 41(2):17-35.
63. Halkitis P.N., Fischgrund B.N., Parsons J.T. Explanations for methamphetamine use among gay and bisexual men in New York City. Substance Use & Misuse 2005, 40(9-10):1331-1345.
64. Hall W., Hando J. Route of administration and adverse effects of amphetamine use among young adults in Sydney. Australia. Drug and Alcohol Review 1994, 13:277-284.
65. Hall W., Ross J., Lynskey M., Law M., Degenhardt L. How many dependent heroin users are there in Australia? NDARC Monograph No. 44 2000, National Drug and Alcohol Research Centre, UNSW, Sydney.
66. Hammer, M. R. (2006). A key to methamphetamine-related literature. [Draft Version 0.9.7]. Bureau of Special Populations, Division of HIV Prevention, AIDS Institute, New York State Department of Health. Retrieved 18.08.07 http://www.nyhealth.gov/diseases/aids/harm_reduction/crystalmeth/docs/meth_literature_index.pdf.
67. Hassan K.M. Current trends of illicit drug use and the country response in Bangladesh 2005, University of Melbourne, Melbourne.
68. Howard J., Hunt N., Arcuri A. A situational assessment and review of the evidence for interventions for the prevention of HIV/AIDS among Occassional, Experimental and Young Injecting Drug Users 2003, UN Interagency and CEEHRN Technical Consultation on Occassional, Experimental and Young Injecting Drug Users in the CEE/CIS and Baltics.
69. Hughes, C. (2005). Exclusive: Iraq fanatics' kill pill. Iraq drug makes rebel fanatics fearless. Mirror.co.uk. Retrieved from http://www.mirror.co.uk/news/tm_objectid=16433322%26method=full%26siteid=94762%26headline=exclusive--iraq-fanatics--kill-pill-name_page.html.
70. Ihunwo A.O., Kayanja F.I.B., Amadi-Ihunwo U.B. Use and perception of the psychostimulant, khat (catha edulis) among three occupational groups in south western Uganda. East African Medical Journal 2004, 81(9):468-473.
71. Jittiwutikarn J., Thongsawat S., Suriyanon V., Maneekarn N., Celentano D., Razak M.H., et al. Hepatitis C infection among drug users in northern Thailand. American Journal of Tropical Medicine and Hygiene 2006, 74:1111-1116.
72. Joe-Laidler K., Morgan P. Kinship and community: The " ice" crisis in Hawaii. Amphetamine misuse: International perspectives on current trends 1997, 163-179. Harwood Academic Publishers, The Netherlands. H. Klee (Ed.).
73. Kalix P. Khat: A plant with amphetamine effects. Journal of Substance Abuse Treatment 1988, 5(3):163-169.
74. Kandela P. Women's rights, a tourist boom, and the power of khat in Yemen. Lancet 2000, 355(9213):1437.
75. Kippax S., Campbell D., Van de Ven P., Crawford J., Prestage G., Knox S., et al. Cultures of sexual adventurism as markers of HIV seroconversion: A case control study in a cohort of Sydney gay men. AIDS Care 1998, 10(6):677-688.
76. Knapp, W., Soares, B., Farrel, M., & Lima, M. (2007). Psychosocial interventions for cocaine and psychostimulant amphetamines related disorders. Cochrane Database System Review, 3. doi:10.1002/14651858.CD003023.pub2.
77. Kozlov A.P., Shaboltas A.V., Toussova O.V., Verevochkin S.V., Masse B.R., Perdue T., et al. HIV incidence and factors associated with HIV acquisition among injection drug users in St Petersburg, Russia. [see comment]. AIDS 2006, 20(6):901-906.
78. Kral A., Bluthenthal R., Lorvick J., Gee L., Bacchetti P., Edlin B. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet 2001, 357:1397-1401.
79. Kraus L., Augustin R., Frischer M., Kümmler P., Uhl A., Wiessing L. Estimating prevalence of problem drug use at national level in countries of the European Union and Norway. Addiction 2003, 98:471-485.
80. Kurtz S.P. Post-circuit blues: Motivations and consequences of crystal meth use among gay men in Miami. AIDS and Behavior 2005, 9(1):63-72.
81. Lee N. Chapter 4: Risks associated with psychostimulant use. Models of intervention and care for psychostimulant users. NDS Monograph Series No. 51 2004, 51-59. Australian Government Department of Health and Ageing, Canberra. 2nd ed.
82. Lelevich V., Kozlovsky A., Vinitskaya A., Maksimchuk V. Drug abuse and illegal drug trafficking in Belarus. Grodno: Programme of assistance for the prevention of drug abuse and drug trafficking in Belarus. Ukraine and Moldova 2006, (BUMAD).
83. Leonard L., DeRubeis E., Pelude L., Medd E., Birkett N., Seto J. I inject less as I have easier access to pipes": Injecting, and sharing of crack-smoking materials, decline as safer crack-smoking resources are distributed. International Journal of Drug Policy 2008, 19(3):255-264.
84. London E.D., Simon S.L., Berman S.M., Mandelkern M.A., Lichtman A.M., Bramen J., et al. Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers. Archives of General Psychiatry 2004, 61(1):73-84.
85. Malta M., Bastos F.I., Pereira-Koller E.M., Cunha M.D., Marques C., Strathdee S.A. A qualitative assessment of long distance truck drivers' vulnerability to HIV/AIDS in Itaja, southern Brazil. AIDS Care 2006, 18(5):489-496.
86. Mathers B., Degenhardt L., Phillips B., Wiessing L., Hickman M., Strathdee S., et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: A systematic review. The Lancet 2008, 372:1733-1745.
87. Matsumoto T., Kamijo A., Miyakawa T., Endo K., Yabana T., Kishimoto H., et al. Methamphetamine in Japan: The consequences of methamphetamine abuse as a function of route of administration. Addiction 2002, 97(7):809-817.
88. Maxwell J.C. Emerging research on methamphetamine. Current Opinion in Psychiatry 2005, 18:235-242.
89. Maxwell J.C., Cravioto P., Galvan F., Cortes Ramirez M., Wallisch L., Spence R.T. Drug use and risk of HIV/AIDS on the Mexico-USA border: A comparison of treatment admissions in both countries. Drug and Alcohol Dependence 2006, 1(82 Suppl.):S85-S93.
90. Maxwell J.C., Rutowski B. The prevalence of methamphetamine and amphetamine abuse in North America: A review of the indicators, 1992-2007. Drug and Alcohol Review 2008, 27(3):229-235.
91. McKetin R., Kelly E., McLaren J. The relationship between crystalline methamphetamine use and methamphetamine dependence. Drug & Alcohol Dependence 2006, 85(3):198-204.
92. McKetin R., McLaren J. The methamphetamine situation in Australia: A review of routine data sources. [Payneham S.A.] 2004, Australasian Centre for Policing Research: National Drug Law Enforcement Fund.
93. McKetin R., McLaren J., Lubman D.I., Hides L. The prevalence of psychotic symptoms among methamphetamine users. Addiction 2006, 101(10):1473-1478.
94. McKirnan D.J., Vanable P.A., Ostrow D.G., Hope B. Expectancies of sexual " escape" and sexual risk among drug and alcohol-involved gay and bisexual men. Journal of Substance Abuse 2001, 13(1-2):137-154.
95. Merson M., O'Malley J., Serwadda D., Apisuk C. The history and challenge of HIV prevention. Lancet 2008, 372:475-488.
96. Mita, A. (2002). Police on alert for 'Crystal Ice'. Cyprus Mail. Retrieved from http://www.cyprus-mail.com/.
97. Mitu, W. (2007). Heroin and yaba flood Dhaka. The Daily Star. Retrieved 08.09.07, from http://thedailystar.net/2007/01/08/d701082501140.htm.
98. Miura H., Fujiki M., Shibata A., Ishikawa K. Prevalence and profile of methamphetamine users in adolescents at a juvenile classification home. Psychiatry & Clinical Neurosciences 2006, 60(3):352-357.
99. Morgan P., Beck J. The legacy and the paradox: Hidden contexts of methamphetamine use in the United States. Amphetamine misuse: International perspectives on current trends 1997, 135-162. Harwood Academic Publishers, The Netherlands. H. Klee (Ed.).
100. Morris K., Parry C. South African methamphetamine boom could fuel further HIV. The Lancet Infectious Diseases 2006, 6(8):471.
101. Nascimento E.C., Nascimento d., Silva E.J.d.P. Alcohol and amphetamines use among long-distance truck drivers, Portuguese. Revista de Saude Publica 2006, 41:290-293.
102. National Surveillance Center on Drug Abuse 2005 Annual report on drug abuse of China 2006, National Institue on Drug Dependence, Peking University, Beijing.
103. Neaigus A., Miller M., Friedman S.R., Hagen D.L., Sifaneck S.J., Ildefonso G., et al. Potential risk factors for the transition to injecting among non-injecting heroin users: A comparison of former injectors and never injectors. Addiction 2001, 96:847-860.
104. Nejo K. Pacific Islands Regional Profile 2003, United Nations International Drug Control Programme Regional Centre for East Asia and the Pacific, Bangkok.
105. O'Brien S., Black E., Roxburgh A., Degenhardt L., Bruno R., Campbell G., et al. Australian Drug Trends 2006: Findings from the Illicit Drug Reporting System (IDRS). NDARC Monograph 60 2007, National Drug and Alcohol Research Centre, University of New South Wales, Sydney.
106. Office of Applied Studies (2006). Treatment Episode Data Set (TEDS) Highlights-2005. Rockville.
107. Panda S. Drug use in the northeastern states of India: 2006, NODC Regional Office for South Asia and the Ministry of Social Justice and Empowerment, Government of India.
108. Parry C.D.H., Myers B., Pluddemann A. Drug policy for methamphetamine use urgently needed. South African Medical Journal, Suid-Afrikaanse Tydskrif Vir Geneeskunde 2004, 94(12):964-965.
109. Patterson T.L., Semple S.J. Sexual risk reduction among HIV-positive drug-using men who have sex with men. Journal of Urban Health 2003, 80(4 Suppl. 3).
110. Patterson T.L., Semple S.J., Fraga M., Bucardo J., De La Torre A., Salazar J., et al. Comparison of sexual and drug use behaviors between female sex workers in Tijuana and Ciudad Juarez, Mexico. Substance Use and Misuse 2006, 41(10):1535-1549.
111. Patterson T., Semple S., Staines H., Lozada R., Orozovich P., Bucardo J., et al. Prevalence and correlates of HIV infection among female sex workers in 2 Mexico-US border cities. The Journal of Infectious Diseases 2008, 197(5):728-732.
112. Pizzey R., Hunt N. Distributing foil from needle and syringe programmes (NSPs) to promote transitions from heroin injecting to chasing: An evaluation. Harm Reduction Journal 2008, 5:24.
113. Rahman N. The inevitable crash. Star Weekend Magazine 2006, 5.
114. Rawson R., Marinelli-Casey P., Anglin M.D., Dickow A., Frazier Y., Gallagher C., et al. A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence [Research Report]. Addiction 2004, 99(6):708-717. June 2004.
115. Rawson R.A., Gonzales R., Brethen P. Treatment of methamphetamine use disorders: An update. Journal of Substance Abuse Treatment 2002, 23(2):145-150.
116. Rawson R.A., Marinelli-Casey P., Anglin M.D., Dickow A., Frazier Y., Gallagher C., et al. A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence. Addiction 2004, 99(6):708-717.
117. Reback C.J., Larkins S., Shoptaw S. Changes in the meaning of sexual risk behaviors among gay and bisexual male methamphetamine abusers before and after drug treatment. AIDS and Behavior 2004, 8(1):87-98.
118. Reccia L., Rocco A., Lioniello M., Fichera G. Amphetamine misuse in southern Italy. British Medical Journal 1995, 311(7017):1433.
119. Reid G., Devaney M.L., Baldwin S. Drug production, trafficking and trade in Asia and Pacific Island countries. Drug & Alcohol Review 2006, 25(6):647-650.
120. Robles R.R., Matos T.D., Deren S., Colon H.M., Sahai H., Marrero C.A., et al. Drug treatment disparities among Hispanic drug-using women in Puerto Rico and New York City. Health Policy 2006, 75(2):159-169.
121. Rose V., Raymond H.F., Kellogg T.A., McFarland W. Assessing the feasibility of harm reduction services for MSM: The late night breakfast buffet study. Harm Reduction Journal 2006, 3(29):8.
122. Ross M., Mattison A., Franklin D. Club drugs and sex on drugs are associated with different motivations for gay circuit party attendance in men. Substance Use & Misuse 2003, 38(8):1173-1183.
123. Samii, B. (2005). Iran: Domestic drug abuse, smuggling on the rise. Radio Free Europe. Retrieved from http://www.payvand.com/news/05/dec/1029.html.
124. Seiden L., Sobol K., Ricaurte G. Amphetamine: Effects on catecholamine systems and behaviour. Annual Reviews of Pharmacology and Toxicology 1993, 33:639-674.
125. Semaan S., Des Jarlais D.C., Malow R. Behavior change and health-related interventions for heterosexual risk reduction among drug users. Substance Use & Misuse 2006, 41:1349-1378.
126. Shearer J. Treatment responses to problematic methamphetamine use: The Australian experience. Interventions for Amphetamine Misuse 2009, Blackwell Publishing, Oxford, pp. 115-128, Chapter 9. R. Pates, D. Riley (Eds.).
127. Shoptaw S., Frosch D. Substance abuse treatment as HIV prevention for men who have sex with men. AIDS and Behavior 2000, 4(2):193-203.
128. Stafford, J., Degenhardt, L., Agaliotis, M., Chanteloup, F., Fischer, J., Matthews, A. et al., (2005). Australian Trends in Ecstasy and Related Drug Markets 2004: Findings from the Party Drugs Initiative (PDI) (No. NDARC Monograph No. 57). Sydney: National Drug and Alcohol Research Centre, University of New South Wales.
129. Storr C.L., Arria A.M., Workman Z.R.L., Anthony J.C. Neighborhood environment and opportunity to try methamphetamine (" ice" ) and marijuana: Evidence from Guam in the Western Pacific region of Micronesia. Substance Use & Misuse 2004, 39(2):253-276.
130. Strathdee S., Case P., Lozada R., Mantsios A., Alvelais J., Pu M., et al. The color of meth: Is it related to adverse health outcomes? An exploratory study in Tijuana, Mexico. American Journal on Addictions 2008, 17(2):111-115.
131. Stryker Meyer, J. (2005). Meth reportedly fueling fanaticism in Iraq. NC Times. Retrieved from http://www.nctimes.com/articles/2005/01/07/news/columnists/another_tilt/20_38_341_6_05.txt.
132. Swift W., Maher L., Sunjic S. Transitions between routes of heroin administration: A study of Caucasian and Indochinese heroin users in south-western Sydney, Australia. Addiction 1999, 94:71-82.
133. Topp L., Darke S., Degenhardt L., Degenhardt L., Kaye S., Darke S. The emergence of potent forms of methamphetamine in Sydney, Australia: A case study of the IDRS as a strategic early warning system. Drug and Alcohol Review 2002, 21(4):341-348. December 2002.
134. Tsay W. Highlights of AMCEWG meeting 2006 2006, Taiwan National Bureau of Controlled Drugs, Taipei.
135. UNAIDS AIDS epidemic update: December 2006 2006, UNAIDS, Geneva.
136. UNAIDS Report on the global AIDS epidemic 2006 2006, UNAIDS, Geneva.
137. United Nations Office on Drugs and Crime Patterns and trends in amphetamine-type stimulants in East Asia and the Pacific: Findings from the 2006 regional ATS questionnaire 2007, United Nations Office on Drugs and Crime Regional Centre for East Asia and the Pacific, Bangkok.
138. United Nations Office on Drugs and Crime World Drug Report 2006 2007, United Nations, Vienna.
139. United Nations Office on Drugs and Crime 2008 Global ATS assessment: Amphetamines and ecstasy 2008, United Nations, Vienna.
140. United Nations Office on Drugs and Crime World Drug Report 2008 2008, United Nations, Vienna.
141. United Nations Office on Drugs and Crime World Drug Report 2009 2009, United Nations, Vienna.
142. UNODC World Drug Report 2009 2009, United Nations, Vienna.
143. US National Drug Intelligence Center (2003). Guam drug threat assessment. Retrieved November 2005, from http://www.usdoj.gov/ndic/pubs4/4001/meth.htm.
144. Volkow N., Fowler J., Wang G.-J., Swanson J. Dopamine in drug abuse and addiction: Results from imaging studies and treatment implications. Molecular Psychiatry 2004, 9:557-569.
145. Wasserheit J. Epidemiological synergy: Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sexually Transmitted Diseases 1992, 19:61-77.
146. Wattanaa W., van Griensvenb F., Rhucharoenpornpanicha O., Manopaiboonb C., Thienkruab W., Bannathama R., et al. Respondent-driven sampling to assess characteristics and estimate the number of injection drug users in Bangkok. Thailand. Drug & Alcohol Dependence 2007, 90:228-233.
147. Westermeyer J. The importance and difficulty of drug research in developing countries: A report from Kabul as timely reminder. Addiction 2004, 99:802-804.
148. Wood E., Stoltz J.-A., Montaner J.S.G., Kerr T. Evaluating methamphetamine use and risks of injection initiation among street youth: The ARYS study. Harm Reduction Journal 2006, 3(18):6.
149. World Bank HIV/AIDS in Bhutan 2006, World Bank, Washington.
150. World Health Organization Neuroscience of psychoactive substance use and dependence 2004, World Health Organization, Geneva.
151. Zabransky T. Methamphetamine in the Czech Republic. Journal of Drug Issues 2007, 37(1):155-180.
152. Zule W.A., Desmond D.P., Morgan P., Joe K.A. An Ethnographic comparison of HIV risk behaviors among heroin and methamphetamine injectors. American Journal of Drug and Alcohol Abuse 1999, 25:1-23.
153. Zweben J., Cohen J., Christian D., Galloway G., Salinardi M., Parent D., et al. Psychiatric symptoms in methamphetamine users. The American Journal on Addictions 2004, 13:181-190.